Respiratory Syncytial Virus Market to Reach USD 4.54 Billion by 2033 as Global Uptake of Next-Generation Vaccines & Monoclonal Antibodies Accelerates

According to DataM Intelligence, the Respiratory Syncytial Virus (RSV) Market Size reached USD 1.95 billion in 2024 and is projected to advance to USD 4.54 billion by 2033, expanding at a strong CAGR ...

How Seattle scientists are helping research a path to an HIV cure

Two new studies provide insights into a possible cure for HIV, and feature the work of researchers from the UW and Fred Hutchinson Cancer Center.

A molecule opens a breach in HIV, providing access to its reservoirs

An international team led by two Université de Montréal researchers has unveiled how a molecule capable of opening the "shell ...

Intratumoral Cancer Therapies Market to Reach USD 630.7 Million by 2033 as Next-Generation Localized Immunotherapies Transform Solid Tumor Treatment

According to DataM Intelligence, the Intratumoral Cancer Therapies Market Size increased from USD 219.79 million in 2023 to USD 246.4 million in 2024, and is expected to climb to USD 630.7 million by ...

GTF: No, bird flu won't really impact your Thanksgiving dinner

A years-long bird flu outbreak is still impacting many turkey farms, but that doesn't mean it's impacting the turkey you are ...
BMJ Global Health

Disease burden due to respiratory syncytial virus infection among under-5 children of India for 2020: a multiplicative model using meta-estimates

Background Respiratory syncytial virus (RSV) is an important cause of acute lower respiratory infections (ALRI) among under-5 ...